PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype-Reference-Cited by-同舟云学术

PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype

Published:2020-08-25 Issue:22 Volume:26 Page:5843-5851
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Guarneri Valentina,Dieci Maria Vittoria^ORCID,Bisagni Giancarlo,Brandes Alba A.,Frassoldati Antonio,Cavanna Luigi^ORCID,Musolino Antonino^ORCID,Giotta Francesco^ORCID,Rimanti Anita,Garrone Ornella^ORCID,Bertone Elena,Cagossi Katia,Nanni Oriana,Piacentini Federico^ORCID,Orvieto Enrico,Griguolo Gaia^ORCID,Curtarello Matteo,Urso Loredana^ORCID,Paré Laia,Chic Nuria,D'Amico Roberto,Prat Aleix,Conte Pierfranco^ORCID

Funder

Agenzia Italiana del Farmaco

Italian Association for Cancer Research

Instituto de Salud Carlos III

Breast Cancer Now

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration;Scientific Reports;2024-08-01

2. Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework;Biomarkers in Medicine;2024-03-15

3. Breast Cancer;Biomedical Aspects of Solid Cancers;2024

4. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer;JAMA Network Open;2023-12-20

5. Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data;Translational Oncology;2023-11